MedTrace Logo

Natural History Study for Patients With Angelman Syndrome

NCT06229769 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-05-20

No results posted yet for this study

Summary

This study is a 9-year natural history study for patients with Angelman syndrome in Belgium (a genetic neurodevelopmental disorder, affecting 500,000 individuals in the world). It includes a 3-year recruitment phase, a 5 year follow-up and a year to analyze the collected data. The investigators plan to include 30 patients with a semi-annual follow-up for 4 years.

The investigators will collect relevant retrospective and prospective data using age-standardized scales and questionnaires for functional motor assessments and global developmental assessment.

Conditions

Sponsors & Collaborators

  • Centre Hospitalier Régional de la Citadelle

    collaborator OTHER

  • SYSNAV

    collaborator INDUSTRY

  • Centre Hospitalier Universitaire de Liege

    lead OTHER

Principal Investigators

  • Laura Vanden Brande · CHR Citadelle

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-10
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06229769 on ClinicalTrials.gov